Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.

Completed · Phase 4 · Has a placebo group

Conditions studied: Heart Failure, Reduced Ejection Fraction

In brief

The purpose of this study was to investigate the effects of initiation of sacubitril/valsartan vs enalapril treatment on objective measures of both waking activity and sleep in subjects with heart failure with reduced ejection fraction.

Key facts

Study ID
NCT02970669
Run by
Novartis Pharmaceuticals
People needed
140
Starts
2016-12-16
Expected to finish
2018-03-19
Last updated by the study team
2021-10-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.